These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33768683)
21. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185 [TBL] [Abstract][Full Text] [Related]
23. A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis. Savage JR; Pulsipher A; Rao NV; Kennedy TP; Prestwich GD; Ryan ME; Lee WY PLoS One; 2016; 11(6):e0157310. PubMed ID: 27308827 [TBL] [Abstract][Full Text] [Related]
24. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages. Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379 [TBL] [Abstract][Full Text] [Related]
25. Synergistic Effect of Biphasic Calcium Phosphate and Platelet-Rich Fibrin Attenuate Markers for Inflammation and Osteoclast Differentiation by Suppressing Kumar A; Mahendra J; Mahendra L; Abdulkarim HH; Sayed M; Mugri MH; Ahmad ZH; Bhati AK; Faqehi HH; Algregri WO; Varadarajan S; Balaji TM; Baeshen HA; Patil S Molecules; 2021 Oct; 26(21):. PubMed ID: 34770985 [TBL] [Abstract][Full Text] [Related]
26. Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation. Wu L; Luo Z; Liu Y; Jia L; Jiang Y; Du J; Guo L; Bai Y; Liu Y Stem Cell Res Ther; 2019 Dec; 10(1):375. PubMed ID: 31805984 [TBL] [Abstract][Full Text] [Related]
27. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. Ihn HJ; Kim YS; Lim S; Bae JS; Jung JC; Kim YH; Park JW; Wang Z; Koh JT; Bae YC; Baek MC; Park EK Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671948 [TBL] [Abstract][Full Text] [Related]
28. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation. Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351 [TBL] [Abstract][Full Text] [Related]
29. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways. Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053 [TBL] [Abstract][Full Text] [Related]
30. A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption. Pokhrel NK; Kim YG; Kim HJ; Kim HJ; Lee JH; Choi SY; Kwon TG; Lee HJ; Kim JY; Lee Y J Periodontol; 2019 May; 90(5):546-554. PubMed ID: 30387495 [TBL] [Abstract][Full Text] [Related]
31. IL-37 alleviates alveolar bone resorption and inflammatory response through the NF-κB/NLRP3 signaling pathway in male mice with periodontitis. Li L; Li J; Li S; Chen H; Wu Y; Qiu Y Arch Oral Biol; 2023 Mar; 147():105629. PubMed ID: 36680836 [TBL] [Abstract][Full Text] [Related]
32. 6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice. Kim YG; Kim MO; Kim SH; Kim HJ; Pokhrel NK; Lee JH; Lee HJ; Kim JY; Lee Y J Periodontol; 2020 Jun; 91(6):809-818. PubMed ID: 31675438 [TBL] [Abstract][Full Text] [Related]
33. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT. Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828 [TBL] [Abstract][Full Text] [Related]
34. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo. Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918 [TBL] [Abstract][Full Text] [Related]
35. Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation. Fu L; Pan F; Jiao Y Immunobiology; 2017 Apr; 222(4):597-603. PubMed ID: 27871781 [TBL] [Abstract][Full Text] [Related]
36. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. Chaisson ML; Branstetter DG; Derry JM; Armstrong AP; Tometsko ME; Takeda K; Akira S; Dougall WC J Biol Chem; 2004 Dec; 279(52):54841-8. PubMed ID: 15485831 [TBL] [Abstract][Full Text] [Related]
37. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571 [TBL] [Abstract][Full Text] [Related]
38. Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway. Zhu S; Hu X; Tao Y; Ping Z; Wang L; Shi J; Wu X; Zhang W; Yang H; Nie Z; Xu Y; Wang Z; Geng D Sci Rep; 2016 Oct; 6():36251. PubMed ID: 27796351 [TBL] [Abstract][Full Text] [Related]
39. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Hyeon S; Lee H; Yang Y; Jeong W Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472 [TBL] [Abstract][Full Text] [Related]
40. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]